New therapies to improve cardiovascular health
EMBL researchers have made new strides into understanding and reversing genetic defects that underlie familial heart disease.
SCIENCE & TECHNOLOGY2023
sciencescience-technology
Human genome editing: regulations, risks, and ethical considerations
Scientists have the technology to edit the human genome. But when should they, and who contributes to these decisions?
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectivesperspectives
Cell sorting enters a new dimension
EMBL researchers, in collaboration with BD Biosciences, have demonstrated a new technology that allows rapid image-based sorting of cells. The new technology represents a major upgrade to flow cytometry and has applications in diverse life science fields.
SCIENCE & TECHNOLOGY2022
sciencescience-technology
New horizons for virtual learning
EMBL's science education department makes the latest scientific research more accessible for teachers and students.
LAB MATTERS2021
eventslab-matters
Powerful genome editing tool recognised by Nobel Prize in Chemistry
The genome editing tool CRISPR–Cas9 – which plays a critical role in EMBL’s research – was recognised by the Nobel Prize in Chemistry.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
From stem cells to neurons
Scientists at EMBL Heidelberg have investigated stem cells and how they differentiate to become neurons. Their approach included an assessment of the complex interplay of molecules during the differentiation process and generated fundamental new insights into the role of a protein called Sox2 in…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Unravelling epigenetic reprogramming
A study conducted by the Hackett group at EMBL Rome has identified key factors controlling the complex system of gene regulation during early embryo development, shedding new light on the mechanisms behind these events and on their evolutionary implications. Their findings are published in Nature…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Silencing the SARS-CoV-2 receptor with epigenetic modifications
EMBL scientists develop a new molecular tool to prevent SARS-CoV-2 infection in mice. This tool is able to cause targeted epigenetic modifications of specific genes in specific cell populations. They will use it in mice to target airway cells that express the ACE2 protein – the receptor that…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Enabling functional genomics studies in individual cells
Scientists at EMBL Heidelberg have developed a new method, called Targeted Perturb-seq (TAP-seq), which increases the scale and precision of functional genomics CRISPR–Cas9 screens by orders of magnitude. Their method overcomes limitations in previous applications of single-cell RNA sequencing,…
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Tracing the origins of cells
Researchers from the Sharpe group at EMBL Barcelona have published a method to track the developmental history of a cell using the gene editing tool CRISPR–Cas9, but without the need to create transgenic organisms.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Tissue dynamics provide clues to human disease
EMBL scientists examine the molecular causes of a rare hereditary disease of the spine and ribs
SCIENCE & TECHNOLOGY2020
sciencescience-technology
2020 EMBL Alumni Award winners announced
Committee recognises outstanding contributions of EMBL alumni to science journalism and genome editing
EMBL ANNOUNCEMENTS2020
alumniembl-announcements
Neural pathways
Exploring the diverse routes by which EMBL scientists are driving forward neurobiology
SCIENCE & TECHNOLOGY2019
sciencescience-technology
Wielding the genetic scissors
What CRISPR may bring for the future of biology, and how it is used at EMBL
SCIENCE & TECHNOLOGY2019
sciencescience-technology
Prioritising cancer drug targets using CRISPR
Large CRISPR screen prioritises hundreds of promising genes for personalised cancer treatment
SCIENCE & TECHNOLOGY2019
sciencescience-technology
DIY Biology kits: what’s really growing inside?
EMBL’s GeneCore steps up to discover the facts and settle disputes
LAB MATTERS2018
lab-matters
Exploring cell identity by mapping genetic networks
ERC grantees Wolfgang Huber and Oliver Stegle share their vision for the next 10 years
SCIENCE & TECHNOLOGY2018
sciencescience-technology
Deleting genes to study how germ cells are born
How embryonic stem cells develop into the germ line
SCIENCE & TECHNOLOGY2018
sciencescience-technology
First interactive model of human cell division
Real-time tracking of proteins during mitosis is now possible using a 4D computer model
SCIENCE & TECHNOLOGY2018
sciencescience-technology
CRISPR: from clipping scissors to word processor
New platform transforms CRISPR gene editor into precision tool
SCIENCE & TECHNOLOGY2018
sciencescience-technology
Fish on fire
New study by Paola Kuri and Maria Leptin shows how inflammation happens in zebrafish in real time
SCIENCE & TECHNOLOGY2017
sciencescience-technology
Gene editing 3.0
Emmanuelle Charpentier sheds light on how CRISPR–Cas9 went from side project to global revolution
SCIENCE & TECHNOLOGY2016
sciencescience-technology
A snapshot of stem cell expression
Study of mouse embryonic stem cells reveals new genes involved in the stem-cell regulatory network.
SCIENCE & TECHNOLOGY2015
sciencescience-technology
Awards & Honours
EMBL scientists regularly receive prestigious awards – meet the latest honourees.
LAB MATTERS2015
lab-matters
Nothing but blue skies
Focusing on basic research is crucial for the development of more advanced genetics techniques
SCIENCE & TECHNOLOGY2014
sciencescience-technology
No results found